Personal information

Switzerland, Greece

Activities

Works (1)

Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS

Cancers
2021-02 | Journal article | Author
Contributors: Jeroen Janssen; Bob Löwenberg; Markus Manz; Mario Bargetzi; Bart Biemond; Peter von dem Borne; Dimitri Breems; Rolf Brouwer; Yves Chalandon; Dries Deeren et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute